Yichang HEC ChangJiang privatisation conditions fulfilled

Yichang HEC ChangJiang Pharmaceutical Co., Ltd. (HKEX:1558) announced today that all pre-conditions for its proposed conditional privatisation by Sunshine Lake Pharma Co., Ltd., via a merger by absorption, have been fulfilled. This follows confirmation from the Stock Exchange approving in principle the listing of Sunshine Lake Pharma's H Shares, including those to be issued as consideration for the share exchange under the merger. The composite document relating to the privatisation is expected to be dispatched on or before June 30, 2025. Shareholders and potential investors are advised to review the announcements and documents published on the Stock Exchange website for detailed information. The privatization remains conditional upon the effectiveness of the merger agreement, with warnings issued regarding potential difficulties for U.S. H Shareholders.